Company / Revenue per Share
SUTRO BIOPHARMA, INC. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$7.47
FY2025
5-year range
$0.92 / $7.47
FY2021-FY2025
Trend
+572.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +572% YoY in FY2025, a notable deviation from the 7-year average annual change of +60%.
Based on SEC 10-K filings.
7.47 in FY2025 with a 5-year CAGR of +35.0%.
Improved from $1.08 to $7.47 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +100.8%
- 5-Year CAGR
- +35.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- SUTRO BIOPHARMA, INC.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 572.4% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.47 | +572.4% |
| FY2024 | $1.11 | +3.2% |
| FY2023 | $1.08 | +16.7% |
| FY2022 | $0.92 | -1.3% |
| FY2021 | $0.93 | -43.8% |
| FY2020 | $1.66 | -26.6% |
| FY2019 | $2.26 | -98.2% |
| FY2018 | $128.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026